[journal]
Folkman J
/ 1995
/ Clinical applications of research on angiogenesis
/ New Engl J Med
333
: 1757~1763
[journal]
Folkman J
/ 2003
/ Angiogenesis and apoptosis
/ Semin Cancer Biol
13
: 159~167
[journal]
Bouck N.
/ 1996
/ How tumors become angiogenic
/ Adv Cancer Res
69
: 135~174
[journal]
Felmeden DC.
/ 2003
/ Angiogenesis : basic pathophysiology and implications for disease
/ Eur Heart J
24
: 586~603
[journal]
Folkman J
/ 1987
/ What is the role of angiogenesis in metastasis from cutaneous melanoma?
/ Eur J Cancer Clin Oncol
23
: 361~363
[journal]
Koch AE.
/ 1986
/ Stimulation of neovascularization by human rheumatoid synovial tissue macrophages
/ Arthritis Rheum
29
: 471~479
[journal]
Kraling BM.
/ 1998
/ A simplified method for growth of human microvascular endothelial cells results in deceased senescence and continued responsiveness to cytokines and growth factors
/ In Vitro Cell Dev Biol Anim
34
: 308~315
[journal]
Leikens S.
/ 2001
/ Angiogenesis : regulators and clinical applications
/ Biochem Pharmacol
61
: 253~270
[journal]
Cornelius LA. .
/ 1995
/ Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration
/ J Invest Dermatol
105
: 170~176
[journal]
Johnson MD.
/ 1994
/ Inhibition of angiogenesis by tissue inhibitor of metalloproteinase
/ J Cell Physiol
160
: 194~202
[journal]
Taraboletti G.
/ 1990
/ Platelet thrombospondin modulates endothelial cell adhesion, motility and growth : a potential angiogenesis regulatory factor
/ J Cell Biol
111
: 765~772
[journal]
Kanda S.
/ 1999
/ Role of Thrombosponidn-1-derived peptide, 4N1K, in FGF-2-induced angiogenesis
/ Exp Cell Res
252
: 262~272
[confproc]
Good DJ.
/ 1990
/ A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
/ Proc Natl Acad Sci USA
87
: 6624~6628
[journal]
Morandi V
/ 1993
/ Roleof thrombospondin in the adhesion of human endothelial cells in primary culture
/ In Vitro Cell Dev Biol Anim
29A
: 585~591
[journal]
Dreyfus M.
/ 1988
/ The build-up of the thrombospondin extracellular matrix. An apparent dependence on synthesis and on preformed fibrillar matrix
/ Eur J Cell Biol
47
: 275~282
[journal]
Lawler J
/ 2000
/ The functions of thrombospondin-1 and-2
/ Curr Opin Cell Biol
12
: 634~640
[journal]
Wang TN.
/ 1995
/ The effect of thrombospondin on oral squamous carcinoma cell invasion of collagen
/ Am J Surg
170
: 502~505
[journal]
Bein K.
/ 2000
/ Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinas activity
/ J Biol Chem
275
: 32167~32173
[journal]
Iruela-Arispe ML.
/ 1999
/ Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1repeats
/ Circulation
100
: 1423~1431
[journal]
Chen H.
/ 1996
/ Metabolism of thrombospondin-2 binding and degradation by 3T3 cells and glycosaminoglycan-variant chinese hamster ovary cells
/ J Biol Chem
271
: 15993~15999
[journal]
Petzelbauer P.
/ 1993
/ Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture
/ J Immunol
151
: 5062~5072
[journal]
Greenwalt DE.
/ 1992
/ Membrane glycoprotein CD36 : a review of its roles in adherence, signal transduction, and transfusion medicine
/ Blood
80
: 1105~1115
[journal]
Swerlick RA.
/ 1992
/ Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro
/ J Immunol
148
: 78~83
[journal]
Frazier WA
/ 1987
/ Thrombospondin : a modular adhesive glycoprotein of platelets and nucleated cells
/ J Cell Biol
105
: 625~632
[journal]
Rigotti A.
/ 1995
/ The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids
/ J Biol Chem
270
: 16221~16224
[journal]
Nicholson AC.
/ 1995
/ Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site
/ Arterioscler Thromb Vasc Biol
15
: 269~275
[journal]
Nozaki S.
/ 1995
/ Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects
/ J Clin Invest
96
: 1859~1865
[journal]
Endemann G.
/ 1993
/ CD36 is a receptor for oxidized low density lipoprotein
/ J Biol Chem
268
: 11811~11816
[journal]
Stern M.
/ 1996
/ Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Mediation by αvβ3/CD36/thrombospondin recognition mechanism and lack of phlogistic response
/ Am J Pathol
149
: 911~921
[journal]
Ren Y.
/ 1995
/ CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis
/ J Exp Med
181
: 1857~1862
[journal]
Silverstein RL.
/ 1992
/ Sense and antisense cDNA transfection of CD36 (Glycoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor
/ J Biol Chem
267
: 16607~16612
[journal]
Bagavandoss P.
/ 1990
/ Specific inhibition of endothelial cell proliferation by thrombospondin
/ Biochem Biophys Res Commun
170
: 867~872
[journal]
de Fraipont F.
/ 2001
/ Thrombospondins and tumor angiogenesis
/ Trends Mol Med
7
: 401~407
[journal]
Guo N.
/ 1997
/ Thrombospondin 1 and type I repeat peptides of thrombospondin 1specifically induce apoptosis of endothelial cells
/ Cancer Res
57
: 1735~1742
[journal]
Tolsma SS.
/ 1993
/ Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity
/ J Cell Biol
122
: 497~511
[journal]
Jaffe EA.
/ 1973
/ Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria
/ J Clin Invest
52
: 2745~2756
[journal]
Passaniti A.
/ 1992
/ Methods in laboratory investigation; A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor
/ Lab Invest
67
: 519~528
[journal]
Akhrat N.
/ 2002
/ The sponge/Matrigel angiogenesis assay
/ Angiogenesis
5
: 75~80
[journal]
Bandyopadhyay A.
/ 2002
/ Extracellular domain of TGF-βtype III receptor inhibits angiogenesis and tumor growth in human cancer cells
/ Oncogene
21
: 3541~3551
[journal]
Weinstat-Saslow D.
/ 1994
/ Transfection of thrombospondin 1complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis
/ Cancer Res
54
: 6504~6511
[journal]
Streit M.
/ 1999
/ Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas
/ Am J Pathol
155
: 441~452
[journal]
Auerbach R.
/ 2003
/ Angiogenesis assays : A critical overview
/ Clin Chem
49
: 32~40
[journal]
Tolsma SS.
/ 1997
/ Lumen formation and other angiogenic activities of cultured capillary endothelial cells are inhibited by thrombospondin-1
/ Microvasc Res
54
: 13~26
[journal]
Friedlander M.
/ 1995
/ Definition of two angiogenic pathways by distinct αν integrins
/ Science
270
: 1500~1502
[journal]
Dawson DW.
/ 1997
/ CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells
/ J Cell Biol
138
: 707~717